http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID759980_PMID24900735

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174512822_AID759980_PMID24900735_VALUE8
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103461731_AID759980_PMID24900735_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174507691_AID759980_PMID24900735_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174512821_AID759980_PMID24900735_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103461641_AID759980_PMID24900735_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174487156_AID759980_PMID24900735_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103461556_AID759980_PMID24900735_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103461526_AID759980_PMID24900735_VALUE1
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08183
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Inhibition of MDR1 in multidrug resistant human A2780/DX3 cells assessed as accumulation of doxorubicin at 5 times compound concentration that giving 5% antiproliferative activity after 4 hrs by cytofluorimetric assay relative to (Z)-8-(4-chlorophenyl)-5-methyl-8-(pent-2-enyl-oxy)-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3(8H)-one
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103461556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103461731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID174487156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103461641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID174512822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103461526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID174512821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID174507691
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID759980

Total number of triples: 21.